
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Hum Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Hum Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Human Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1662-5161</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25339884</article-id><article-id pub-id-type="pmc">4186290</article-id><article-id pub-id-type="doi">10.3389/fnhum.2014.00779</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Original Research Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Two Alzheimer&#x02019;s disease risk genes increase entorhinal cortex volume in young adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>DiBattista</surname><given-names>Amanda Marie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/164682"/></contrib><contrib contrib-type="author"><name><surname>Stevens</surname><given-names>Benson W.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rebeck</surname><given-names>G. William</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/9966"/></contrib><contrib contrib-type="author"><name><surname>Green</surname><given-names>Adam E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/80275"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Neuroscience, Georgetown University Medical Center</institution><country>Washington, DC, USA</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Psychology, Georgetown University</institution><country>Washington, DC, USA</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Aron K. Barbey, University of Illinois at Urbana-Champaign, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Daniel Llano, University of Illinois at Urbana-Champaign, USA; Edward Huey, Columbia University in the City of New York, USA</p></fn><corresp id="fn001">*Correspondence: Adam E. Green, Department of Psychology, Georgetown University, 37th and O Streets, NW, 302 C White-Gravenor, Washington, DC 20057, USA e-mail: <email xlink:type="simple">aeg58@georgetown.edu</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to the journal Frontiers in Human Neuroscience.</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>8</volume><elocation-id>779</elocation-id><history><date date-type="received"><day>30</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 DiBattista, Stevens, Rebeck and Green.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Alzheimer&#x02019;s disease (AD) risk genes alter brain structure and function decades before disease onset. Apolipoprotein E (APOE) is the strongest known genetic risk factor for AD, and a related gene, apolipoprotein J (APOJ), also affects disease risk. However, the extent to which these genes affect brain structure in young adults remains unclear. Here, we report that AD risk alleles of these two genes, APOE-&#x003b5;4 and APOJ-C, cumulatively alter brain volume in young adults. Using voxel-based morphometry (VBM) in 57 individuals, we examined the entorhinal cortex, one of the earliest brain regions affected in AD pathogenesis. Apolipoprotein E-&#x003b5;4 carriers exhibited higher right entorhinal cortex volume compared to non-carriers. Interestingly, APOJ-C risk genotype was associated with higher bilateral entorhinal cortex volume in non-APOE-&#x003b5;4 carriers. To determine the combined disease risk of APOE and APOJ status per subject, we used cumulative odds ratios as regressors for volumetric measurements. Higher disease risk corresponded to greater right entorhinal cortex volume. These results suggest that, years before disease onset, two key AD genetic risk factors may exert influence on the structure of a brain region where AD pathogenesis takes root.</p></abstract><kwd-group><kwd>APOE</kwd><kwd>APOJ</kwd><kwd>CLU</kwd><kwd>VBM</kwd><kwd>entorhinal cortex</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="64"/><page-count count="7"/><word-count count="6115"/></counts></article-meta></front><body><sec sec-type="introduction" id="s1"><title>Introduction</title><p>Multiple genetic polymorphisms have been shown to increase Alzheimer&#x02019;s disease (AD) risk without guaranteeing its onset (Bertram et al., <xref rid="B6" ref-type="bibr">2007</xref>). Though the mechanisms of genetic risk are largely unknown, one possibility is that risk gene-dependent vulnerabilities and age-dependent vulnerabilities may interact to trigger neurodegeneration (Risacher et al., <xref rid="B48" ref-type="bibr">2010</xref>; Reinvang et al., <xref rid="B47" ref-type="bibr">2013</xref>). Genome-wide association studies have repeatedly shown that the &#x003b5;4 allele of the apolipoprotein E (<italic>APOE</italic>) gene is the strongest known genetic risk factor for AD, increasing risk by 200&#x02013;300% and decreasing age of onset, in a dose-dependent manner (Farrer et al., <xref rid="B20" ref-type="bibr">1997</xref>; Bertram et al., <xref rid="B6" ref-type="bibr">2007</xref>; Harold et al., <xref rid="B29" ref-type="bibr">2009</xref>; Fei and Jianhua, <xref rid="B21" ref-type="bibr">2013</xref>). A related risk factor, apolipoprotein J (<italic>APOJ</italic>, also known as clusterin, CLU), also modestly increases AD risk, with the <italic>APOJ</italic>-C risk allele increasing AD risk by 10&#x02013;15% (Harold et al., <xref rid="B29" ref-type="bibr">2009</xref>; Lambert et al., <xref rid="B38" ref-type="bibr">2009</xref>). These two AD risk genes encode similar proteins that associate with lipoproteins in the brain (Koch et al., <xref rid="B36" ref-type="bibr">2001</xref>; Elliott et al., <xref rid="B18" ref-type="bibr">2010</xref>) to interact with a shared family of cell surface receptors (Kounnas et al., <xref rid="B37" ref-type="bibr">1995</xref>; Leeb et al., <xref rid="B39" ref-type="bibr">2014</xref>) that promote neurite outgrowth (Nathan et al., <xref rid="B44" ref-type="bibr">1994</xref>; Kang et al., <xref rid="B33" ref-type="bibr">2005</xref>), cholesterol metabolism (for review, see Holtzman et al., <xref rid="B30" ref-type="bibr">2012</xref>), and clearance of the AD pathological hallmark, amyloid-&#x003b2; (Demattos et al., <xref rid="B13" ref-type="bibr">2004</xref>).</p><p><italic>Apolipoprotein E</italic> genotype is associated with accelerated atrophy in the brain during disease progression (Shen et al., <xref rid="B53" ref-type="bibr">2010</xref>), and the gray matter density in the medial temporal lobe (MTL) of <italic>APOE</italic>-&#x003b5;4 carriers is particularly sensitive to this type of atrophy (Thomann et al., <xref rid="B58" ref-type="bibr">2008</xref>; Fei and Jianhua, <xref rid="B21" ref-type="bibr">2013</xref>). While the effect of <italic>APOE</italic> genotype on MTL atrophy has been well established in older adults, effects on the young brain are less clear. Whole brain analyses in healthy <italic>APOE</italic>-&#x003b5;4 carriers report increased (Alexander et al., <xref rid="B1" ref-type="bibr">2012</xref>), decreased (Wishart et al., <xref rid="B61" ref-type="bibr">2006</xref>; O&#x02019;dwyer et al., <xref rid="B45" ref-type="bibr">2012</xref>; Knickmeyer et al., <xref rid="B35" ref-type="bibr">2013</xref>), or unchanged (Mondadori et al., <xref rid="B43" ref-type="bibr">2007</xref>; Filippini et al., <xref rid="B22" ref-type="bibr">2009</xref>; Dennis et al., <xref rid="B14" ref-type="bibr">2010</xref>; Samuraki et al., <xref rid="B50" ref-type="bibr">2012</xref>; Stein et al., <xref rid="B54" ref-type="bibr">2012</xref>; Matura et al., <xref rid="B42" ref-type="bibr">2014</xref>) MTL volume depending on the experimental parameters. Although less studied than <italic>APOE</italic>-&#x003b5;4, <italic>APOJ</italic> was also not associated with MTL differences in a large scale genome-wide association study (GWAS) meta-analysis (Stein et al., <xref rid="B54" ref-type="bibr">2012</xref>). As with <italic>APOE</italic>, it may be that more sensitive analyses are necessary to detect differences induced by <italic>APOJ</italic> risk. Thus, our aim was to assay gray matter volume in a particular area of the MTL that is susceptible to AD pathology very early in the disease, the entorhinal cortex (Braak et al., <xref rid="B7" ref-type="bibr">2011</xref>). The entorhinal cortex facilitates communication between the hippocampus and neocortex for memory consolidation. We sought to test whether <italic>APOE</italic> and <italic>APOJ</italic> genotypes affected entorhinal cortex volume in a cohort of young adults. In addition, the putative functional similarities between the proteins these genes encode (Kounnas et al., <xref rid="B37" ref-type="bibr">1995</xref>; Koch et al., <xref rid="B36" ref-type="bibr">2001</xref>; Elliott et al., <xref rid="B18" ref-type="bibr">2010</xref>; Leeb et al., <xref rid="B39" ref-type="bibr">2014</xref>) prompted us to explore whether <italic>APOE</italic> and <italic>APOJ</italic> polymorphisms may have a cumulative effect, which would suggest the potential of a common pathway for these risk factors in a region critical for AD pathogenesis.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and methods</title><sec id="s2-1"><title>Participants</title><p>Participants were healthy, right-handed university students and community members (<italic>n</italic> = 57, 33 male, 74% Caucasian). Each participant provided informed consent for MRI and genotyping. These participants ranged from 18&#x02013;35 years of age (mean = 21.8, standard deviation = 4.0) with no history of mental illness, psychoactive medication or brain injury. All procedures received IRB approval prior to the study.</p></sec><sec id="s2-2"><title>Genotyping</title><p>We performed genotyping of the human APOJ (or CLU) polymorphism at rs11136000, human APOE polymorphism at rs429358 (codon 112), and human APOE polymorphism at rs7412 (codon 158) using the TaqMan assay (Applied Biosystems). A reaction volume of 25 &#x003bc;L containing 50 ng DNA, 5 mL MgCl<sub>2</sub> and 1X TaqMan Universal PCR Master Mix containing AmpliTaq Gold DNA Polymerase was amplified using 40 cycles of 15 s at 95&#x000b0;C and 1 min at 60&#x000b0;C. A total of 0.2 &#x003bc;M of each of the sequence-specific probes 5&#x02032;-6FAM ACCAAAGCCACACCAGCTATCAAAA[T]TCT CTAACGGGCCCTTGCCACTTGA-TAMRA-3&#x02032; and 5&#x02032;-VIC-ACCAAAGCCA CACCAGCTATCAAAA[C]TCTCTAACGGGCCC TTGCCACTTGA-TAMRA-3&#x02032; were used in the allelic discrimination assay for APOJ. For the allelic discrimination assay for APOE, sequence specific probes were also used: 5&#x02032; VIC-CCGCGATGCCGATGACCTGCAGAAG [C]GCCTGGCAGTGTACCAGGCCGGGGC&#x02013;TAMRA-3&#x02032; and 5&#x02032;FAM-CCGCGATGCC GATGACCTGCAGAAG[T]GCCTGGCAGT GTACCAGGCCGGGGC-TAMRA-3&#x02032; for rs7412 and 5&#x02032; VIC-GCTGGGCGCG GACATGGAGGACGTG[C]GCGGCCGCCTGGTGCAGTACCGCGG-TAMRA-3&#x02032; and 5&#x02032;FAM-GCTGGGCGCGGACATGGAGGACGTG[T]GCGGCCGCCTGGT GCAGTACCGCGG-TAMRA-3&#x02032; for rs429358. Allele detection and genotype calling were performed using the ABI 7700 and Sequence Detection Software (Applied Biosystems). All calls scored at least 95% quality values and were verified by 100% recall on ~20% of samples that were re-tested for quality control.</p></sec><sec id="s2-3"><title>Image acquisition, processing, and analysis</title><p>Magnetic resonance imaging images were acquired using a 3-T Allegra System (Siemens, Erlangen, Germany). Whole-brain structural T1-weighted magnetization-prepared rapid gradient-echo (MPRAGE) images were acquired for each subject (FOV = 256 mm; 256 &#x000d7; 256 matrix; 1 &#x000d7; 1 mm in-plane resolution, 1.25 mm thick axial slices, 1 average). All MPRAGE images were processed using SPM8<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> on MATLAB 2010b<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref>.</p><p>Voxel-Based Morphometry (VBM) was performed using the DARTEL toolbox for SPM (Ashburner and Friston, <xref rid="B3" ref-type="bibr">2000</xref>; Ashburner, <xref rid="B2" ref-type="bibr">2007</xref>). All default settings were used except where noted otherwise. Images were aligned into AC/PC orientation prior to segmenting into gray matter, white matter, and cerebrospinal fluid. All participants&#x02019; gray and white matter images were then simultaneously registered together to create a study specific template to reduce between-participant variability. The template was then used to normalize all images into the standard Montreal Neurological Institute (MNI) space using the &#x0201c;DARTEL Normalize to MNI Space&#x0201d; program, utilizing the &#x0201c;preserve amount&#x0201d; option to retain the volumetric data of the original images. The images were smoothed using a Gaussian kernel with 8 mm full-width half maximum (FWHM). For statistical analyses, masks for the left and right entorhinal cortex were created from the Juelich Histological Atlas (Eickhoff et al., <xref rid="B16" ref-type="bibr">2005</xref>). The mean gray matter volumes were then extracted from the participants MNI aligned gray matter images with both masks. Lastly, to account for global brain volume differences, intracranial brain volume for each participant was used to normalize extracted gray matter volumes. Intracranial brain volume was calculated by combining the total brain volumes found in native space gray matter, white matter, and cerebrospinal fluid images for each participant. Left (<italic>p</italic> = 0.3028, <italic>p</italic> = 0.5027) and right (<italic>p</italic> = 0.2231, <italic>p</italic> = 0.2118) extracted gray matter volumes for the entorhinal and primary visual cortex, respectively, were normally distributed according to the Shapiro-Wilk test; therefore, parametric statistics were conducted.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3-1"><title>Genotyping</title><p>We isolated and purified DNA from 57 participants to genotype for two genes associated with increased risk of late onset AD: <italic>APOE</italic> and <italic>APOJ</italic>. The following numbers of subjects per group were included in analyses: &#x003b5;2/&#x003b5;2 (2 subjects), &#x003b5;2/&#x003b5;3 (6 subjects), &#x003b5;3/&#x003b5;3 (40 subjects), &#x003b5;3/&#x003b5;4 (9 subjects) (Table <xref ref-type="table" rid="T1">1</xref>). Because the &#x003b5;2 allele is associated with a protective effect from AD, analyses were conducted with and without &#x003b5;2-carriers. There were two subjects with the &#x003b5;2/&#x003b5;4 genotype, and results from these two subjects were excluded from all analyses. The distribution of <italic>APOE</italic> genotypes was as expected for the United States, with allele frequencies of 0.064 (&#x003b5;2), 0.783 (&#x003b5;3), and 0.145 (&#x003b5;4) (Eisenberg et al., <xref rid="B17" ref-type="bibr">2010</xref>). Of these subjects, there were 15 <italic>APOJ</italic>-C/C subjects, 33 <italic>APOJ</italic>-C/T subjects, and 9 <italic>APOJ</italic>-T/T subjects. Both of the excluded subjects with the <italic>APOE</italic>-&#x003b5;2/&#x003b5;4 genotype also had the <italic>APOJ</italic>-C/T genotype, and were excluded from all analyses. The distribution of <italic>APOJ</italic> genotypes was also as expected based on previous studies, with allele frequencies of 0.447 (T) and 0.553 (C) (Golenkina et al., <xref rid="B25" ref-type="bibr">2010</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Demographic information</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Genotype</th><th align="center" rowspan="1" colspan="1">Sex</th><th align="center" rowspan="1" colspan="1">Age</th><th align="center" rowspan="1" colspan="1">O.R. APOE, APOJ</th><th align="center" rowspan="1" colspan="1">Risk score</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">APOE-&#x003b5;4/APOJ-C</td><td align="center" rowspan="1" colspan="1">M: 5; F: 3</td><td align="center" rowspan="1" colspan="1">19.8 &#x000b1; 1.5</td><td align="center" rowspan="1" colspan="1">4.3, 1.22</td><td align="center" rowspan="1" colspan="1">1.657</td></tr><tr><td align="left" rowspan="1" colspan="1">APOE-&#x003b5;4/</td><td align="center" rowspan="1" colspan="1">M: 1; F: 0</td><td align="center" rowspan="1" colspan="1">19 &#x000b1; 0</td><td align="center" rowspan="1" colspan="1">4.3, 1</td><td align="center" rowspan="1" colspan="1">1.459</td></tr><tr><td align="left" rowspan="1" colspan="1">APOJ-non-C</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">APOE-non-&#x003b5;4/</td><td align="center" rowspan="1" colspan="1">M: 21; F: 19</td><td align="center" rowspan="1" colspan="1">21.8 &#x000b1; 3.5</td><td align="center" rowspan="1" colspan="1">0.6 or 1, 1.22</td><td align="center" rowspan="1" colspan="1">0.199</td></tr><tr><td align="left" rowspan="1" colspan="1">APOJ-C</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">APOE-non-&#x003b5;4/</td><td align="center" rowspan="1" colspan="1">M: 6; F: 2</td><td align="center" rowspan="1" colspan="1">23.8 &#x000b1; 6.9</td><td align="center" rowspan="1" colspan="1">0.6 or 1, 1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">APOJ-non-C</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>Values for age represent the mean &#x000b1; standard deviation. Odds ratios (O.R.) are normalized to APOE-&#x003b5;3 and non-APOJ-C, making these values &#x0201c;1&#x0201d;. Risk scores shown are sums of the natural log of the odds ratios. Non-APOE-&#x003b5;4 group includes APOE-&#x003b5;2 carriers that have O.R. of 0.6</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>MRI</title><p>To test the hypothesis that the <italic>APOE</italic>-&#x003b5;4 and <italic>APOJ</italic>-C risk alleles alter the structure of a brain region affected early in AD pathogenesis (Hyman et al., <xref rid="B31" ref-type="bibr">1984</xref>; Gomez-Isla et al., <xref rid="B26" ref-type="bibr">1996</xref>; Braak et al., <xref rid="B7" ref-type="bibr">2011</xref>), we extracted gray matter volumetric measurements within the left and right entorhinal cortical regions of interest for each genotype group. We then conducted <italic>a priori</italic>
<italic>t</italic>-tests to interrogate the relationship of each polymorphism with entorhinal cortex volume. A comparison of <italic>APOE</italic>-&#x003b5;4-positive vs. <italic>APOE</italic>-&#x003b5;4-negative individuals, collapsed across <italic>APOJ</italic> genotype, revealed significantly greater right entorhinal cortex volume for <italic>APOE</italic>-&#x003b5;4 carriers by 8.47%, <italic>t</italic><sub>(55)</sub> = 2.29, <italic>p</italic> = 0.0259 (Figure <xref ref-type="fig" rid="F1">1</xref>, *<italic>p</italic> &#x0003c; 0.05). This effect persisted when <italic>APOE</italic>-&#x003b5;2 carriers were removed from analyses, <italic>t</italic><sub>(47)</sub> = 2.185, <italic>p</italic> = 0.0339. Differences in left entorhinal cortex volume in <italic>APOE</italic>-&#x003b5;4 carriers compared to non-carriers did not reach statistical significance, <italic>t</italic><sub>(55)</sub> = 1.261, <italic>p</italic> = 0.2126 (Figure <xref ref-type="fig" rid="F1">1</xref>). To examine the effect of <italic>APOJ</italic>-C in the absence of the <italic>APOE</italic>-&#x003b5;4 allele, we grouped non-<italic>APOE</italic>-&#x003b5;4-carriers by <italic>APOJ-C</italic> status (<italic>APOJ</italic>-C vs. non-<italic>APOJ-C-carriers)</italic>. This comparison revealed that, among non-<italic>APOE</italic>-&#x003b5;4-carriers, <italic>APOJ</italic>-C carriers had greater left entorhinal cortex volume by 12.33%, <italic>t</italic><sub>(46)</sub> = 2.05, <italic>p</italic> = 0.0458, and greater right entorhinal cortex volume by 8.16%, <italic>t</italic><sub>(46)</sub> = 2.03, <italic>p</italic> = 0.0485 (Figure <xref ref-type="fig" rid="F2">2</xref>, *<italic>p</italic> &#x0003c; 0.05). This effect persisted when <italic>APOE</italic>-&#x003b5;2 carriers were removed from analyses for the right entorhinal cortex (<italic>t</italic><sub>(38)</sub> = 2.03, <italic>p</italic> = 0.0492), but not the left entorhinal cortex (<italic>t</italic><sub>(38)</sub> = 1.89, <italic>p</italic> = 0.067).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold><italic>Apolipoprotein E</italic>-&#x003b5;4 AD risk genotype is associated with greater right entorhinal cortex volume</bold>. A two-tailed <italic>t</italic>-test demonstrates that when participants are grouped based on <italic>APOE</italic> status alone, the risk allele (<italic>APOE</italic>-&#x003b5;4) is associated with higher right entorhinal cortex volume compared to the non-risk alleles <italic>t</italic><sub>(55)</sub> = 2.29, <italic>p</italic> = 0.0259. (*<italic>p</italic> &#x0003c; 0.05, <italic>n</italic> = 48 non-<italic>APOE</italic>-&#x003b5;4 carriers, <italic>n</italic> = 9 <italic>APOE</italic>-&#x003b5;4 carriers).</p></caption><graphic xlink:href="fnhum-08-00779-g0001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold><italic>Apolipoprotein J</italic></bold><bold>-C AD risk genotype is associated with greater bilateral entorhinal cortex volume, in noncarriers of</bold>
<bold><italic>APOE</italic></bold><bold>-&#x003b5;4</bold>. A two-tailed <italic>t</italic>-test demonstrates that when non-<italic>APOE</italic>-&#x003b5;4 carriers are grouped based on <italic>APOJ</italic> status, <italic>APOJ</italic>-C carriers have higher left entorhinal cortex volume, <italic>t</italic><sub>(46)</sub> = 2.05, <italic>p</italic> = 0.0458, and right entorhinal cortex volume, <italic>t</italic><sub>(46)</sub> = 2.03, <italic>p</italic> =0.0485. (*<italic>p</italic> &#x0003c; 0.05, <italic>n</italic> = 40 <italic>APOJ</italic>-C carriers, <italic>n</italic> = 8 non-<italic>APOJ</italic>-C carriers).</p></caption><graphic xlink:href="fnhum-08-00779-g0002"/></fig><p>Based on a putative shared biological pathway, we hypothesized that AD risk factors <italic>APOE</italic>-&#x003b5;4 and <italic>APOJ</italic>-C work together to alter brain structure in young adults. We explored the possibility of a combined effect of <italic>APOE</italic> and <italic>APOJ</italic>, although the interpretation is somewhat limited by the small number in one of the groups (<italic>APOE</italic>-&#x003b5;4, <italic>APOJ</italic>-non-C; Table <xref ref-type="table" rid="T1">1</xref>). A <italic>t</italic>-test of the highest risk group (<italic>APOE</italic>-&#x003b5;4, <italic>APOJ</italic>-C, <italic>n</italic> = 8) vs. the lowest risk group (non-<italic>APOE</italic>-&#x003b5;4, non-<italic>APOJ</italic>-C, <italic>n</italic> = 6) reveals that greater AD risk is associated with greater right entorhinal cortex volume by 13.89%, <italic>t</italic><sub>(12)</sub> = 2.27, <italic>p</italic> = 0.0421, but no difference in left entorhinal cortex volume, <italic>p</italic> = 0.09 (Figure <xref ref-type="fig" rid="F3">3</xref>, *<italic>p</italic> &#x0003c; 0.05). When including <italic>APOE</italic>-&#x003b5;2 carriers in the analyses, this effect on the right entorhinal cortex persists, <italic>t</italic><sub>(20)</sub> = 2.12, <italic>p</italic> = 0.0464, without changing the effect on the left entorhinal cortex, <italic>p</italic> &#x0003e; 0.1. To directly investigate the combined effect AD risk, we tested whether a &#x0201c;risk score&#x0201d; variable was predictive of entorhinal cortex volume. Risk score was weighted by each risk allele&#x02019;s odds ratio for AD (Bertram et al., <xref rid="B6" ref-type="bibr">2007</xref>; Carrasquillo et al., <xref rid="B10" ref-type="bibr">2010</xref>; Table <xref ref-type="table" rid="T1">1</xref>). Specifically, risk score was calculated based on <italic>APOE</italic> and <italic>APOJ</italic> genotype by combining the natural log of the odds ratio for each participant to create a single risk score per participant. Values for the two risk alleles were added to generate an additive risk score. This risk scores then served as a regressor for volumetric measurements. The additive risk score was associated with higher right entorhinal cortex volume, &#x003b2; = 5.10, <italic>F</italic><sub>(55)</sub> = 5.47, <italic>p</italic> = 0.023, but not left entorhinal cortex volume, <italic>p</italic> &#x0003e; 0.1. This effect persisted as a strong trend in the absence of the <italic>APOE</italic>-&#x003b5;4/non-<italic>APOJ</italic>-C group, &#x003b2; = 4.36, <italic>F</italic><sub>(54)</sub> = 3.89, <italic>p</italic> = 0.0537. As a control measure, we also measured gray matter volume in one of the last areas affected by AD (primary visual cortex, V1). As anticipated, neither left (&#x003b2; = 0.3313, <italic>p</italic> = 0.9117) nor right (&#x003b2; = &#x02212;0.6976, <italic>p</italic> = 0.8168) V1 volumes were correlated with risk score. Moreover, no APOE-genotype associated differences were observed in the left (<italic>p</italic> = 0.8115) or right (<italic>p</italic> = 0.8446) V1. Overall, these results suggest the possibility that AD risk-related genes <italic>APOE</italic> and <italic>APOJ</italic> additively affect brain volume in young people within the entorhinal cortex.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold><italic>Apolipoprotein E</italic></bold>
<bold>and</bold>
<bold><italic>APOJ</italic></bold>
<bold>risk genotypes show an additive association with greater right entorhinal cortex volume</bold>. A two-tailed <italic>t</italic>-test shows that when the highest risk group (<italic>APOE</italic>-&#x003b5;4, <italic>APOJ</italic>-C, <italic>n</italic> = 8) is compared to the lowest risk group (non-<italic>APOE</italic>-&#x003b5;4, non-<italic>APOJ</italic>-C, <italic>n</italic> = 6), greater AD risk is associated with greater right entorhinal cortex volume by 13.89%, <italic>t</italic><sub>(12)</sub> = 2.27, <italic>p</italic> = 0.0421 (*<italic>p</italic> &#x0003c; 0.05), but not left entorhinal cortex volume, <italic>p</italic> &#x0003e; 0.09.</p></caption><graphic xlink:href="fnhum-08-00779-g0003"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p><italic>Apolipoprotein E</italic> is the strongest genetic risk factor for AD, and the entorhinal cortex is one of the earliest brain regions to develop neuropathological lesions and atrophy in AD (Hyman et al., <xref rid="B31" ref-type="bibr">1984</xref>; Gomez-Isla et al., <xref rid="B26" ref-type="bibr">1996</xref>; Braak et al., <xref rid="B7" ref-type="bibr">2011</xref>). Because pathogenesis of AD begins as early as two decades prior to the presentation of clinical symptoms (Bateman et al., <xref rid="B4" ref-type="bibr">2012</xref>), it is plausible that a series of genetically-induced differences in brain structure&#x02014;such as entorhinal cortex volume&#x02014;could accumulate with aging to increase vulnerability to AD later in life. Here, we assayed entorhinal cortex volume in a cohort of young adults to directly investigate whether <italic>APOE</italic> and <italic>APOJ</italic> genetic AD risk alters the structure of this region in early adulthood. <italic>Apolipoprotein E</italic>-&#x003b5;4 carriers exhibited greater entorhinal cortex volume in the right hemisphere (Figure <xref ref-type="fig" rid="F1">1</xref>), and further analysis revealed that the <italic>APOJ</italic>-C genotype was associated with higher bilateral entorhinal cortex volume in <italic>APOE</italic>-&#x003b5;4 non-carriers (Figure <xref ref-type="fig" rid="F2">2</xref>). The highest risk group (<italic>APOE</italic>-&#x003b5;4, <italic>APOJ</italic>-C) exhibited greater entorhinal cortex volume compared to the lowest risk group (non-<italic>APOE</italic>-&#x003b5;4, non-<italic>APOJ</italic>-C) (Figure <xref ref-type="fig" rid="F3">3</xref>). When additive odds ratios of <italic>APOE</italic> and <italic>APOJ</italic> served as regressors for volumetric measurements, higher disease risk was associated with greater right entorhinal cortex volume.</p><p>Volumetric studies report conflicting results when examining MTL volume in <italic>APOE</italic> risk carriers depending on the experimental parameters. For instance, one study of infants 1&#x02013;3 months old with family histories of schizophrenia found <italic>APOE</italic>-associated differences in temporal lobe volume, including the hippocampus and entorhinal cortex (Knickmeyer et al., <xref rid="B35" ref-type="bibr">2013</xref>). However, this effect was not seen in a follow up study with 6&#x02013;25 month old infants with no family history of schizophrenia (Dean et al., <xref rid="B12" ref-type="bibr">2014</xref>). Similarly, while some evidence has suggested that healthy <italic>APOE</italic>-&#x003b5;4 positive adults exhibit decreased bilateral hippocampal volume (O&#x02019;dwyer et al., <xref rid="B45" ref-type="bibr">2012</xref>) and gray matter density in the right medial temporal region (Wishart et al., <xref rid="B61" ref-type="bibr">2006</xref>), another study in young adults reported that <italic>APOE</italic>-&#x003b5;4 carriers showed relative increases in volume in the vicinity of the hippocampus (Alexander et al., <xref rid="B1" ref-type="bibr">2012</xref>). Further contributing to the controversy, other studies have suggested no differences in MTL volume by <italic>APOE</italic> genotype (Mondadori et al., <xref rid="B43" ref-type="bibr">2007</xref>; Filippini et al., <xref rid="B22" ref-type="bibr">2009</xref>; Dennis et al., <xref rid="B14" ref-type="bibr">2010</xref>; Samuraki et al., <xref rid="B50" ref-type="bibr">2012</xref>; Stein et al., <xref rid="B54" ref-type="bibr">2012</xref>; Matura et al., <xref rid="B42" ref-type="bibr">2014</xref>). Less research has focused on the lesser AD risk factor, <italic>APOJ</italic>, and its effect on MTL volume. The limited extant research has suggested no difference exists in the MTL by <italic>APOJ</italic> genotype (Bralten et al., <xref rid="B8" ref-type="bibr">2011</xref>; Stein et al., <xref rid="B54" ref-type="bibr">2012</xref>). A meta-analysis of GWAS including over 7000 cognitively normal subjects showed that <italic>APOJ</italic> genotype was not significantly associated with hippocampal volume (Stein et al., <xref rid="B54" ref-type="bibr">2012</xref>). However, this study did not focus on young adults or target the entorhinal cortex specifically. While the <italic>APOJ</italic>-C risk allele has no significant effect on gray matter volume by whole brain analyses in young adults, a related risk gene, CR1, was associated with smaller local gray matter volume in the entorhinal cortex in a prior study (Bralten et al., <xref rid="B8" ref-type="bibr">2011</xref>).</p><p>The inconsistency of extant evidence could be due to differences in age, gender, exclusion criteria, statistical methods, family history, and how each region of interest was defined across studies. Another explanation may be that the entorhinal cortex is a relatively small region within the MTL, and few studies explicitly target the entorhinal cortex. Thus, it is possible that changes in entorhinal cortex volume are not large enough to alter volume of the MTL as a whole. By specifically targeting the entorhinal cortex in our study, we were able to detect differences in this relatively small MTL structure that may have otherwise been below the threshold for detection.</p><p>Our results indicate that the effects of <italic>APOE</italic> and <italic>APOJ</italic> may be stronger in the right hemisphere. Medial temporal lobe asymmetry has been linked with AD and disease progression. For instance, <italic>APOE</italic>-&#x003b5;4 carriers have thinner left entorhinal cortex compared to the right, while those without <italic>APOE</italic>-&#x003b5;4 show this asymmetry in the presence of AD pathology (Donix et al., <xref rid="B15" ref-type="bibr">2013</xref>). Individuals with subjective memory impairment had reduced volumes of the hippocampus and entorhinal cortex bilaterally (Striepens et al., <xref rid="B57" ref-type="bibr">2010</xref>). However, <italic>APOE</italic>-&#x003b5;4 carriers without this impairment performed better on episodic memory tests and had larger right hippocampal volumes, as opposed to those with impairment performing worse with smaller right hippocampal volumes (Striepens et al., <xref rid="B56" ref-type="bibr">2011</xref>). Interestingly, differences in symmetry were also reported in delusional AD patients with greater right temporal horn sizes than left, while non-delusional patients did not show this asymmetry (Geroldi et al., <xref rid="B23" ref-type="bibr">2000</xref>). Although asymmetry effects have not yet reported for <italic>APOJ</italic>, it is possible that <italic>APOE</italic> may work in conjunction with <italic>APOJ</italic> to induce asymmetry.</p><p>With aging, reductions in MTL volume in the hippocampus and entorhinal cortex are correlated with cognitive decline in the elderly (Bergfield et al., <xref rid="B5" ref-type="bibr">2010</xref>; Raz et al., <xref rid="B46" ref-type="bibr">2010</xref>; Varon et al., <xref rid="B60" ref-type="bibr">2011</xref>). However, reductions in gray matter volume during the course of brain development in adolescence and early adulthood, correlate with increased synaptic pruning (Gogtay et al., <xref rid="B24" ref-type="bibr">2004</xref>). Thus, increased entorhinal cortex volume during this developmental window could indicate a deficit in neural efficiency. Our study involved individuals of an average age of 21.8 years old, all of whom are at these later stages of brain development. Prior evidence has linked the <italic>APOJ</italic>-C risk allele to abnormal brain development through decreased white matter integrity (Braskie et al., <xref rid="B9" ref-type="bibr">2011</xref>) and subsequent altered coupling between the hippocampus and prefrontal cortex during memory processing, mirroring disrupted connectivity in patients (Erk et al., <xref rid="B19" ref-type="bibr">2011</xref>). Other evidence has also linked <italic>APOE</italic>-&#x003b5;4 to abnormal brain structural and functional development in young risk allele carriers, suggesting that <italic>APOE</italic> and <italic>APOJ</italic> risk may impede the pruning process in the entorhinal cortex.</p><p>Alternatively, these findings could contribute to evidence suggesting that the <italic>APOE</italic> and <italic>APOJ</italic> risk genes confer an evolutionary advantage early in life, but confer a disadvantage later in life by increasing AD risk. This antagonistic pleiotropy hypothesis of <italic>APOE</italic> and <italic>APOJ</italic> risk has been proposed in other contexts (e.g., see Tuminello and Han, <xref rid="B59" ref-type="bibr">2011</xref>; Stevens et al., <xref rid="B55" ref-type="bibr">2014</xref>). College-aged young adults carrying the <italic>APOE</italic>-&#x003b5;4 allele have an advantage in verbal fluency, decision making, and memory (Zetterberg et al., <xref rid="B62" ref-type="bibr">2009</xref>; Marchant et al., <xref rid="B41" ref-type="bibr">2010</xref>; Jochemsen et al., <xref rid="B32" ref-type="bibr">2012</xref>; Rusted et al., <xref rid="B49" ref-type="bibr">2013</xref>; Green et al., <xref rid="B27" ref-type="bibr">2014</xref>), but these advantages disappear by middle age and give way to impairment in old age. These beneficial effects early in life could be due in part to increased volume in the entorhinal cortex, allowing for more effective processing of memory-associated information.</p><p>Finally, larger entorhinal cortex volume in <italic>APOE</italic> and <italic>APOJ</italic> risk carriers could indicate more neuroinflammation in the entorhinal cortex of young adults. It has been postulated that <italic>APOE</italic>-&#x003b5;4 may increase neuroinflammation during aging, thus increasing susceptibility to dementia later in life (e.g., for review, see Guo et al., <xref rid="B28" ref-type="bibr">2004</xref>; Kim et al., <xref rid="B34" ref-type="bibr">2009</xref>). Several studies have also linked <italic>APOJ</italic>-C risk to decreased CLU levels (Schurmann et al., <xref rid="B52" ref-type="bibr">2011</xref>), which are thought to serve an anti-inflammatory role (Savkovic et al., <xref rid="B51" ref-type="bibr">2007</xref>). Glia can contribute to half of brain volume changes (Snell, <xref rid="B64" ref-type="bibr">2009</xref>), and studies have shown that <italic>APOE</italic>-&#x003b5;4 is associated with increased neuroinflammation (Guo et al., <xref rid="B28" ref-type="bibr">2004</xref>; Chen et al., <xref rid="B11" ref-type="bibr">2005</xref>; Maezawa et al., <xref rid="B40" ref-type="bibr">2006</xref>; Zhu et al., <xref rid="B63" ref-type="bibr">2012</xref>). Because the entorhinal cortex is one of the earliest affected brain areas in AD, it is possible that the increase in entorhinal cortex volume could be due to a deficit in <italic>APOE</italic> and <italic>APOJ</italic> carriers to control neuroinflammation in the young adult brain.</p><p>Overall, our findings in a young adult cohort indicate an additive effect of two of the strongest AD risk factors on a brain locus at the epicenter of AD pathogenesis. Entorhinal cortex volume increased as a function of increasing <italic>APOE</italic> and <italic>APOJ</italic> genetic AD risk. These results contribute to a growing literature characterizing genetic markers of AD risk in the young brain, long before the first overt signals of Alzheimer&#x02019;s appear. Thus, these findings inform our understanding of the role of these genetic risk factors in the normal brain, and contribute to the development of biomarker targets for future preventive AD therapies.</p></sec><sec id="s5"><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>This work was supported by NIH R01 AG035379, P01 AG030128 (G. William Rebeck), grants from Partners in Research and the American Legacy Foundation (Adam E. Green), and NIH NINDS 5T32NS041218 (Amanda M. DiBattista). Samples from the National Cell Repository for Alzheimer&#x02019;s Disease, which receives government support under a cooperative agreement grant U24 AG21886 awarded by the National Institute on Aging, were used in this study.</p></ack><fn-group><fn id="fn0001"><p><sup>1</sup><ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm/software/spm8/">http://www.fil.ion.ucl.ac.uk/spm/software/spm8/</ext-link></p></fn><fn id="fn0002"><p><sup>2</sup><ext-link ext-link-type="uri" xlink:href="http://www.mathworks.com/products/matlab/">http://www.mathworks.com/products/matlab/</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>G. E.</given-names></name><name><surname>Bergfield</surname><given-names>K. L.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Reiman</surname><given-names>E. M.</given-names></name><name><surname>Hanson</surname><given-names>K. D.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Gray matter network associated with risk for Alzheimer&#x02019;s disease in young to middle-aged adults</article-title>. <source>Neurobiol. Aging</source>
<volume>33</volume>, <fpage>2723</fpage>&#x02013;<lpage>2732</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.01.014</pub-id><pub-id pub-id-type="pmid">22405043</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>A fast diffeomorphic image registration algorithm</article-title>. <source>Neuroimage</source>
<volume>38</volume>, <fpage>95</fpage>&#x02013;<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.07.007</pub-id><pub-id pub-id-type="pmid">17761438</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>J.</given-names></name><name><surname>Friston</surname><given-names>K. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Voxel-based morphometry&#x02013;the methods</article-title>. <source>Neuroimage</source>
<volume>11</volume>, <fpage>805</fpage>&#x02013;<lpage>821</lpage>
<pub-id pub-id-type="doi">10.1006/nimg.2000.0582</pub-id><pub-id pub-id-type="pmid">10860804</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>R. J.</given-names></name><name><surname>Xiong</surname><given-names>C.</given-names></name><name><surname>Benzinger</surname><given-names>T. L.</given-names></name><name><surname>Fagan</surname><given-names>A. M.</given-names></name><name><surname>Goate</surname><given-names>A.</given-names></name><name><surname>Fox</surname><given-names>N. C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Clinical and biomarker changes in dominantly inherited Alzheimer&#x02019;s disease</article-title>. <source>N. Engl. J. Med.</source>
<volume>367</volume>, <fpage>795</fpage>&#x02013;<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1202753</pub-id><pub-id pub-id-type="pmid">22784036</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergfield</surname><given-names>K. L.</given-names></name><name><surname>Hanson</surname><given-names>K. D.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Teipel</surname><given-names>S. J.</given-names></name><name><surname>Hampel</surname><given-names>H.</given-names></name><name><surname>Rapoport</surname><given-names>S. I.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging</article-title>. <source>Neuroimage</source>
<volume>49</volume>, <fpage>1750</fpage>&#x02013;<lpage>1759</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.09.051</pub-id><pub-id pub-id-type="pmid">19796692</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertram</surname><given-names>L.</given-names></name><name><surname>Mcqueen</surname><given-names>M. B.</given-names></name><name><surname>Mullin</surname><given-names>K.</given-names></name><name><surname>Blacker</surname><given-names>D.</given-names></name><name><surname>Tanzi</surname><given-names>R. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database</article-title>. <source>Nat. Genet.</source>
<volume>39</volume>, <fpage>17</fpage>&#x02013;<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1038/ng1934</pub-id><pub-id pub-id-type="pmid">17192785</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>Thal</surname><given-names>D. R.</given-names></name><name><surname>Ghebremedhin</surname><given-names>E.</given-names></name><name><surname>Del Tredici</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years</article-title>. <source>J. Neuropathol. Exp. Neurol.</source>
<volume>70</volume>, <fpage>960</fpage>&#x02013;<lpage>969</lpage>
<pub-id pub-id-type="doi">10.1097/nen.0b013e318232a379</pub-id><pub-id pub-id-type="pmid">22002422</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bralten</surname><given-names>J.</given-names></name><name><surname>Franke</surname><given-names>B.</given-names></name><name><surname>Arias-Vasquez</surname><given-names>A.</given-names></name><name><surname>Heister</surname><given-names>A.</given-names></name><name><surname>Brunner</surname><given-names>H. G.</given-names></name><name><surname>Fernandez</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>CR1 genotype is associated with entorhinal cortex volume in young healthy adults</article-title>. <source>Neurobiol. Aging</source>
<volume>32</volume>, <fpage>2106.e7</fpage>&#x02013;<lpage>2106.e11</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.05.017</pub-id><pub-id pub-id-type="pmid">21726919</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braskie</surname><given-names>M. N.</given-names></name><name><surname>Jahanshad</surname><given-names>N.</given-names></name><name><surname>Stein</surname><given-names>J. L.</given-names></name><name><surname>Barysheva</surname><given-names>M.</given-names></name><name><surname>Mcmahon</surname><given-names>K. L.</given-names></name><name><surname>De Zubicaray</surname><given-names>G. I.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Common Alzheimer&#x02019;s disease risk variant within the CLU gene affects white matter microstructure in young adults</article-title>. <source>J. Neurosci.</source>
<volume>31</volume>, <fpage>6764</fpage>&#x02013;<lpage>6770</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5794-10.2011</pub-id><pub-id pub-id-type="pmid">21543606</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasquillo</surname><given-names>M. M.</given-names></name><name><surname>Belbin</surname><given-names>O.</given-names></name><name><surname>Hunter</surname><given-names>T. A.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Bisceglio</surname><given-names>G. D.</given-names></name><name><surname>Zou</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Replication of CLU, CR1 and PICALM associations with alzheimer disease</article-title>. <source>Arch. Neurol.</source>
<volume>67</volume>, <fpage>961</fpage>&#x02013;<lpage>964</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2010.147</pub-id><pub-id pub-id-type="pmid">20554627</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Averett</surname><given-names>N. T.</given-names></name><name><surname>Manelli</surname><given-names>A.</given-names></name><name><surname>Ladu</surname><given-names>M. J.</given-names></name><name><surname>May</surname><given-names>W.</given-names></name><name><surname>Ard</surname><given-names>M. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia</article-title>. <source>J. Alzheimers Dis.</source>
<volume>7</volume>, <fpage>25</fpage>&#x02013;<lpage>35</lpage>
<pub-id pub-id-type="pmid">15750212</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>D. C.</given-names><suffix>3rd</suffix></name><name><surname>Jerskey</surname><given-names>B. A.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Protas</surname><given-names>H.</given-names></name><name><surname>Thiyyagura</surname><given-names>P.</given-names></name><name><surname>Roontiva</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Brain differences in infants at differential genetic risk for late-onset alzheimer disease: a cross-sectional imaging study</article-title>. <source>JAMA Neurol.</source>
<volume>71</volume>, <fpage>11</fpage>&#x02013;<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2013.4544</pub-id><pub-id pub-id-type="pmid">24276092</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demattos</surname><given-names>R. B.</given-names></name><name><surname>Cirrito</surname><given-names>J. R.</given-names></name><name><surname>Parsadanian</surname><given-names>M.</given-names></name><name><surname>May</surname><given-names>P. C.</given-names></name><name><surname>O&#x02019;dell</surname><given-names>M. A.</given-names></name><name><surname>Taylor</surname><given-names>J. W.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo</article-title>. <source>Neuron</source>
<volume>41</volume>, <fpage>193</fpage>&#x02013;<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1016/s0896-6273(03)00850-x</pub-id><pub-id pub-id-type="pmid">14741101</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>N. A.</given-names></name><name><surname>Browndyke</surname><given-names>J. N.</given-names></name><name><surname>Stokes</surname><given-names>J.</given-names></name><name><surname>Need</surname><given-names>A.</given-names></name><name><surname>Burke</surname><given-names>J. R.</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>K. A.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers</article-title>. <source>Alzheimers Dement.</source>
<volume>6</volume>, <fpage>303</fpage>&#x02013;<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2009.07.003</pub-id><pub-id pub-id-type="pmid">19744893</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donix</surname><given-names>M.</given-names></name><name><surname>Burggren</surname><given-names>A. C.</given-names></name><name><surname>Scharf</surname><given-names>M.</given-names></name><name><surname>Marschner</surname><given-names>K.</given-names></name><name><surname>Suthana</surname><given-names>N. A.</given-names></name><name><surname>Siddarth</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer&#x02019;s disease</article-title>. <source>Psychiatry Res.</source>
<volume>214</volume>, <fpage>212</fpage>&#x02013;<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.pscychresns.2013.09.006</pub-id><pub-id pub-id-type="pmid">24080518</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eickhoff</surname><given-names>S. B.</given-names></name><name><surname>Stephan</surname><given-names>K. E.</given-names></name><name><surname>Mohlberg</surname><given-names>H.</given-names></name><name><surname>Grefkes</surname><given-names>C.</given-names></name><name><surname>Fink</surname><given-names>G. R.</given-names></name><name><surname>Amunts</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data</article-title>. <source>Neuroimage</source>
<volume>25</volume>, <fpage>1325</fpage>&#x02013;<lpage>1335</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.12.034</pub-id><pub-id pub-id-type="pmid">15850749</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>D. T.</given-names></name><name><surname>Kuzawa</surname><given-names>C. W.</given-names></name><name><surname>Hayes</surname><given-names>M. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations and evolutionary history</article-title>. <source>Am. J. Phys. Anthropol.</source>
<volume>143</volume>, <fpage>100</fpage>&#x02013;<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1002/ajpa.21298</pub-id><pub-id pub-id-type="pmid">20734437</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>D. A.</given-names></name><name><surname>Weickert</surname><given-names>C. S.</given-names></name><name><surname>Garner</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>Apolipoproteins in the brain: implications for neurological and psychiatric disorders</article-title>. <source>Clin. Lipidol.</source>
<volume>51</volume>, <fpage>555</fpage>&#x02013;<lpage>573</lpage>
<pub-id pub-id-type="doi">10.2217/clp.10.37</pub-id><pub-id pub-id-type="pmid">21423873</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erk</surname><given-names>S.</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><name><surname>Opitz von Boberfeld</surname><given-names>C.</given-names></name><name><surname>Esslinger</surname><given-names>C.</given-names></name><name><surname>Schnell</surname><given-names>K.</given-names></name><name><surname>Kirsch</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Hippocampal function in healthy carriers of the CLU Alzheimer&#x02019;s disease risk variant</article-title>. <source>J. Neurosci.</source>
<volume>31</volume>, <fpage>18180</fpage>&#x02013;<lpage>18184</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.4960-11.2011</pub-id><pub-id pub-id-type="pmid">22159129</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>L. A.</given-names></name><name><surname>Cupples</surname><given-names>L. A.</given-names></name><name><surname>Haines</surname><given-names>J. L.</given-names></name><name><surname>Hyman</surname><given-names>B.</given-names></name><name><surname>Kukull</surname><given-names>W. A.</given-names></name><name><surname>Mayeux</surname><given-names>R.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium</article-title>. <source>JAMA</source>
<volume>278</volume>, <fpage>1349</fpage>&#x02013;<lpage>1356</lpage>
<pub-id pub-id-type="doi">10.1001/jama.278.16.1349</pub-id><pub-id pub-id-type="pmid">9343467</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>M.</given-names></name><name><surname>Jianhua</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Apolipoprotein epsilon4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer&#x02019;s disease: a meta-analysis of prospective studies</article-title>. <source>J. Mol. Neurosci.</source>
<volume>50</volume>, <fpage>257</fpage>&#x02013;<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1007/s12031-012-9934-y</pub-id><pub-id pub-id-type="pmid">23242623</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippini</surname><given-names>N.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Wetten</surname><given-names>S.</given-names></name><name><surname>Gibson</surname><given-names>R. A.</given-names></name><name><surname>Borrie</surname><given-names>M.</given-names></name><name><surname>Guzman</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer&#x02019;s disease</article-title>. <source>Neuroimage</source>
<volume>44</volume>, <fpage>724</fpage>&#x02013;<lpage>728</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.10.003</pub-id><pub-id pub-id-type="pmid">19013250</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geroldi</surname><given-names>C.</given-names></name><name><surname>Laakso</surname><given-names>M. P.</given-names></name><name><surname>Decarli</surname><given-names>C.</given-names></name><name><surname>Beltramello</surname><given-names>A.</given-names></name><name><surname>Bianchetti</surname><given-names>A.</given-names></name><name><surname>Soininen</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer&#x02019;s disease: a volumetric MRI study</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>
<volume>68</volume>, <fpage>93</fpage>&#x02013;<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.68.1.93</pub-id><pub-id pub-id-type="pmid">10601411</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogtay</surname><given-names>N.</given-names></name><name><surname>Giedd</surname><given-names>J. N.</given-names></name><name><surname>Lusk</surname><given-names>L.</given-names></name><name><surname>Hayashi</surname><given-names>K. M.</given-names></name><name><surname>Greenstein</surname><given-names>D.</given-names></name><name><surname>Vaituzis</surname><given-names>A. C.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Dynamic mapping of human cortical development during childhood through early adulthood</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>101</volume>, <fpage>8174</fpage>&#x02013;<lpage>8179</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0402680101</pub-id><pub-id pub-id-type="pmid">15148381</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golenkina</surname><given-names>S. A.</given-names></name><name><surname>Gol&#x02019;tsov</surname><given-names>A.</given-names></name><name><surname>Kuznetsova</surname><given-names>I. L.</given-names></name><name><surname>Grigorenko</surname><given-names>A. P.</given-names></name><name><surname>Andreeva</surname><given-names>T. V.</given-names></name><name><surname>Reshetov</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer&#x02019;s disease patients and in normal cohorts from Russian populations</article-title>. <source>Mol. Biol. (Mosk)</source>
<volume>44</volume>, <fpage>620</fpage>&#x02013;<lpage>626</lpage>
<pub-id pub-id-type="pmid">20873220</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Isla</surname><given-names>T.</given-names></name><name><surname>West</surname><given-names>H. L.</given-names></name><name><surname>Rebeck</surname><given-names>G. W.</given-names></name><name><surname>Harr</surname><given-names>S. D.</given-names></name><name><surname>Growdon</surname><given-names>J. H.</given-names></name><name><surname>Locascio</surname><given-names>J. J.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer&#x02019;s disease</article-title>. <source>Ann. Neurol.</source>
<volume>39</volume>, <fpage>62</fpage>&#x02013;<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410390110</pub-id><pub-id pub-id-type="pmid">8572669</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>A. E.</given-names></name><name><surname>Gray</surname><given-names>J. R.</given-names></name><name><surname>Deyoung</surname><given-names>C. G.</given-names></name><name><surname>Mhyre</surname><given-names>T. R.</given-names></name><name><surname>Padilla</surname><given-names>R.</given-names></name><name><surname>Dibattista</surname><given-names>A. M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>A combined effect of two Alzheimer&#x02019;s risk genes on medial temporal activity during executive attention in young adults</article-title>. <source>Neuropsychologia</source>
<volume>56C</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2013.12.020</pub-id><pub-id pub-id-type="pmid">24388797</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Ladu</surname><given-names>M. J.</given-names></name><name><surname>Van Eldik</surname><given-names>L. J.</given-names></name></person-group> (<year>2004</year>). <article-title>A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity</article-title>. <source>J. Mol. Neurosci.</source>
<volume>23</volume>, <fpage>205</fpage>&#x02013;<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1385/jmn:23:3:205</pub-id><pub-id pub-id-type="pmid">15181248</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harold</surname><given-names>D.</given-names></name><name><surname>Abraham</surname><given-names>R.</given-names></name><name><surname>Hollingworth</surname><given-names>P.</given-names></name><name><surname>Sims</surname><given-names>R.</given-names></name><name><surname>Gerrish</surname><given-names>A.</given-names></name><name><surname>Hamshere</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer&#x02019;s disease</article-title>. <source>Nat. Genet.</source>
<volume>41</volume>, <fpage>1088</fpage>&#x02013;<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1038/ng.440</pub-id><pub-id pub-id-type="pmid">19734902</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtzman</surname><given-names>D. M.</given-names></name><name><surname>Herz</surname><given-names>J.</given-names></name><name><surname>Bu</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease</article-title>. <source>Cold Spring Harb. Perspect. Med.</source>
<volume>2</volume>:<fpage>a006312</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a006312</pub-id><pub-id pub-id-type="pmid">22393530</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>B. T.</given-names></name><name><surname>Van Hoesen</surname><given-names>G. W.</given-names></name><name><surname>Damasio</surname><given-names>A. R.</given-names></name><name><surname>Barnes</surname><given-names>C. L.</given-names></name></person-group> (<year>1984</year>). <article-title>Alzheimer&#x02019;s disease: cell-specific pathology isolates the hippocampal formation</article-title>. <source>Science</source>
<volume>225</volume>, <fpage>1168</fpage>&#x02013;<lpage>1170</lpage>
<pub-id pub-id-type="doi">10.1126/science.6474172</pub-id><pub-id pub-id-type="pmid">6474172</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jochemsen</surname><given-names>H. M.</given-names></name><name><surname>Muller</surname><given-names>M.</given-names></name><name><surname>van der Graaf</surname><given-names>Y.</given-names></name><name><surname>Geerlings</surname><given-names>M. I.</given-names></name></person-group> (<year>2012</year>). <article-title>APOE epsilon4 differentially influences change in memory performance depending on age. The SMART-MR study</article-title>. <source>Neurobiol. Aging</source>
<volume>33</volume>, <fpage>832.e15</fpage>&#x02013;<lpage>832.e22</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.07.016</pub-id><pub-id pub-id-type="pmid">21908077</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S. W.</given-names></name><name><surname>Shin</surname><given-names>Y. J.</given-names></name><name><surname>Shim</surname><given-names>Y. J.</given-names></name><name><surname>Jeong</surname><given-names>S. Y.</given-names></name><name><surname>Park</surname><given-names>I. S.</given-names></name><name><surname>Min</surname><given-names>B. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Clusterin interacts with SCLIP (SCG10-like protein) and promotes neurite outgrowth of PC12 cells</article-title>. <source>Exp. Cell Res.</source>
<volume>309</volume>, <fpage>305</fpage>&#x02013;<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2005.06.012</pub-id><pub-id pub-id-type="pmid">16038898</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Basak</surname><given-names>J. M.</given-names></name><name><surname>Holtzman</surname><given-names>D. M.</given-names></name></person-group> (<year>2009</year>). <article-title>The role of apolipoprotein E in Alzheimer&#x02019;s disease</article-title>. <source>Neuron</source>
<volume>63</volume>, <fpage>287</fpage>&#x02013;<lpage>303</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.06.026</pub-id><pub-id pub-id-type="pmid">19679070</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knickmeyer</surname><given-names>R. C.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Geng</surname><given-names>X.</given-names></name><name><surname>Woolson</surname><given-names>S.</given-names></name><name><surname>Hamer</surname><given-names>R. M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Common variants in psychiatric risk genes predict brain structure at birth</article-title>. <source>Cereb. Cortex</source>
<volume>24</volume>, <fpage>2721</fpage>&#x02013;<lpage>2731</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bht125</pub-id><pub-id pub-id-type="pmid">23689636</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>S.</given-names></name><name><surname>Donarski</surname><given-names>N.</given-names></name><name><surname>Goetze</surname><given-names>K.</given-names></name><name><surname>Kreckel</surname><given-names>M.</given-names></name><name><surname>Stuerenburg</surname><given-names>H. J.</given-names></name><name><surname>Buhmann</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Characterization of four lipoprotein classes in human cerebrospinal fluid</article-title>. <source>J. Lipid Res.</source>
<volume>42</volume>, <fpage>1143</fpage>&#x02013;<lpage>1151</lpage>
<pub-id pub-id-type="pmid">11441143</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kounnas</surname><given-names>M. Z.</given-names></name><name><surname>Loukinova</surname><given-names>E. B.</given-names></name><name><surname>Stefansson</surname><given-names>S.</given-names></name><name><surname>Harmony</surname><given-names>J. A.</given-names></name><name><surname>Brewer</surname><given-names>B. H.</given-names></name><name><surname>Strickland</surname><given-names>D. K.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin</article-title>. <source>J. Biol. Chem.</source>
<volume>270</volume>, <fpage>13070</fpage>&#x02013;<lpage>13075</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.22.13070</pub-id><pub-id pub-id-type="pmid">7768901</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>J. C.</given-names></name><name><surname>Heath</surname><given-names>S.</given-names></name><name><surname>Even</surname><given-names>G.</given-names></name><name><surname>Campion</surname><given-names>D.</given-names></name><name><surname>Sleegers</surname><given-names>K.</given-names></name><name><surname>Hiltunen</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer&#x02019;s disease</article-title>. <source>Nat. Genet.</source>
<volume>41</volume>, <fpage>1094</fpage>&#x02013;<lpage>1099</lpage>
<pub-id pub-id-type="doi">10.1038/ng.439</pub-id><pub-id pub-id-type="pmid">19734903</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeb</surname><given-names>C.</given-names></name><name><surname>Eresheim</surname><given-names>C.</given-names></name><name><surname>Nimpf</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway</article-title>. <source>J. Biol. Chem.</source>
<volume>289</volume>, <fpage>4161</fpage>&#x02013;<lpage>4172</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m113.529271</pub-id><pub-id pub-id-type="pmid">24381170</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maezawa</surname><given-names>I.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name><name><surname>Montine</surname><given-names>T. J.</given-names></name><name><surname>Montine</surname><given-names>K. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice</article-title>. <source>J. Neuroinflammation</source>
<volume>3</volume>:<fpage>10</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-3-10</pub-id><pub-id pub-id-type="pmid">16603079</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchant</surname><given-names>N. L.</given-names></name><name><surname>King</surname><given-names>S. L.</given-names></name><name><surname>Tabet</surname><given-names>N.</given-names></name><name><surname>Rusted</surname><given-names>J. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers</article-title>. <source>Neuropsychopharmacology</source>
<volume>35</volume>, <fpage>1090</fpage>&#x02013;<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2009.214</pub-id><pub-id pub-id-type="pmid">20072115</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matura</surname><given-names>S.</given-names></name><name><surname>Prvulovic</surname><given-names>D.</given-names></name><name><surname>Jurcoane</surname><given-names>A.</given-names></name><name><surname>Hartmann</surname><given-names>D.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><name><surname>Scheibe</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Differential effects of the ApoE4 genotype on brain structure and function</article-title>. <source>Neuroimage</source>
<volume>89</volume>, <fpage>81</fpage>&#x02013;<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.11.042</pub-id><pub-id pub-id-type="pmid">24296331</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondadori</surname><given-names>C. R.</given-names></name><name><surname>de Quervain</surname><given-names>D. J.</given-names></name><name><surname>Buchmann</surname><given-names>A.</given-names></name><name><surname>Mustovic</surname><given-names>H.</given-names></name><name><surname>Wollmer</surname><given-names>M. A.</given-names></name><name><surname>Schmidt</surname><given-names>C. F.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers</article-title>. <source>Cereb. Cortex</source>
<volume>17</volume>, <fpage>1934</fpage>&#x02013;<lpage>1947</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhl103</pub-id><pub-id pub-id-type="pmid">17077159</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>B. P.</given-names></name><name><surname>Bellosta</surname><given-names>S.</given-names></name><name><surname>Sanan</surname><given-names>D. A.</given-names></name><name><surname>Weisgraber</surname><given-names>K. H.</given-names></name><name><surname>Mahley</surname><given-names>R. W.</given-names></name><name><surname>Pitas</surname><given-names>R. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro</article-title>. <source>Science</source>
<volume>264</volume>, <fpage>850</fpage>&#x02013;<lpage>852</lpage>
<pub-id pub-id-type="doi">10.1126/science.8171342</pub-id><pub-id pub-id-type="pmid">8171342</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;dwyer</surname><given-names>L.</given-names></name><name><surname>Lamberton</surname><given-names>F.</given-names></name><name><surname>Matura</surname><given-names>S.</given-names></name><name><surname>Tanner</surname><given-names>C.</given-names></name><name><surname>Scheibe</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study</article-title>. <source>PLoS One</source>
<volume>7</volume>:<fpage>e48895</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0048895</pub-id><pub-id pub-id-type="pmid">23152815</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raz</surname><given-names>N.</given-names></name><name><surname>Ghisletta</surname><given-names>P.</given-names></name><name><surname>Rodrigue</surname><given-names>K. M.</given-names></name><name><surname>Kennedy</surname><given-names>K. M.</given-names></name><name><surname>Lindenberger</surname><given-names>U.</given-names></name></person-group> (<year>2010</year>). <article-title>Trajectories of brain aging in middle-aged and older adults: regional and individual differences</article-title>. <source>Neuroimage</source>
<volume>51</volume>, <fpage>501</fpage>&#x02013;<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.03.020</pub-id><pub-id pub-id-type="pmid">20298790</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinvang</surname><given-names>I.</given-names></name><name><surname>Espeseth</surname><given-names>T.</given-names></name><name><surname>Westlye</surname><given-names>L. T.</given-names></name></person-group> (<year>2013</year>). <article-title>APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer&#x02019;s disease</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>37</volume>, <fpage>1322</fpage>&#x02013;<lpage>1335</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.05.006</pub-id><pub-id pub-id-type="pmid">23701948</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risacher</surname><given-names>S. L.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>West</surname><given-names>J. D.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Mcdonald</surname><given-names>B. C.</given-names></name><name><surname>Beckett</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort</article-title>. <source>Neurobiol. Aging</source>
<volume>31</volume>, <fpage>1401</fpage>&#x02013;<lpage>1418</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.04.029</pub-id><pub-id pub-id-type="pmid">20620664</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusted</surname><given-names>J. M.</given-names></name><name><surname>Evans</surname><given-names>S. L.</given-names></name><name><surname>King</surname><given-names>S. L.</given-names></name><name><surname>Dowell</surname><given-names>N.</given-names></name><name><surname>Tabet</surname><given-names>N.</given-names></name><name><surname>Tofts</surname><given-names>P. S.</given-names></name></person-group> (<year>2013</year>). <article-title>APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures</article-title>. <source>Neuroimage</source>
<volume>65</volume>, <fpage>364</fpage>&#x02013;<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.10.010</pub-id><pub-id pub-id-type="pmid">23063453</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuraki</surname><given-names>M.</given-names></name><name><surname>Matsunari</surname><given-names>I.</given-names></name><name><surname>Chen</surname><given-names>W. P.</given-names></name><name><surname>Shima</surname><given-names>K.</given-names></name><name><surname>Yanase</surname><given-names>D.</given-names></name><name><surname>Takeda</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Glucose metabolism and gray-matter concentration in apolipoprotein E epsilon4 positive normal subjects</article-title>. <source>Neurobiol. Aging</source>
<volume>33</volume>, <fpage>2321</fpage>&#x02013;<lpage>2323</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.11.020</pub-id><pub-id pub-id-type="pmid">22188720</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savkovic</surname><given-names>V.</given-names></name><name><surname>Gantzer</surname><given-names>H.</given-names></name><name><surname>Reiser</surname><given-names>U.</given-names></name><name><surname>Selig</surname><given-names>L.</given-names></name><name><surname>Gaiser</surname><given-names>S.</given-names></name><name><surname>Sack</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>356</volume>, <fpage>431</fpage>&#x02013;<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.02.148</pub-id><pub-id pub-id-type="pmid">17359935</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurmann</surname><given-names>B.</given-names></name><name><surname>Wiese</surname><given-names>B.</given-names></name><name><surname>Bickel</surname><given-names>H.</given-names></name><name><surname>Weyerer</surname><given-names>S.</given-names></name><name><surname>Riedel-Heller</surname><given-names>S. G.</given-names></name><name><surname>Pentzek</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Association of the Alzheimer&#x02019;s disease clusterin risk allele with plasma clusterin concentration</article-title>. <source>J. Alzheimers Dis.</source>
<volume>25</volume>, <fpage>421</fpage>&#x02013;<lpage>424</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2011-110251</pub-id><pub-id pub-id-type="pmid">21422520</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Risacher</surname><given-names>S. L.</given-names></name><name><surname>Nho</surname><given-names>K.</given-names></name><name><surname>Swaminathan</surname><given-names>S.</given-names></name><name><surname>West</surname><given-names>J. D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort</article-title>. <source>Neuroimage</source>
<volume>53</volume>, <fpage>1051</fpage>&#x02013;<lpage>1063</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.01.042</pub-id><pub-id pub-id-type="pmid">20100581</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Snell</surname><given-names>R. S.</given-names></name></person-group> (<year>2009</year>). <source>Clinical Neuro-Anatomy.</source> 7th Edn. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Lippincott, Williams &#x00026; Wilkins, 104</publisher-name></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>J. L.</given-names></name><name><surname>Medland</surname><given-names>S. E.</given-names></name><name><surname>Vasquez</surname><given-names>A. A.</given-names></name><name><surname>Hibar</surname><given-names>D. P.</given-names></name><name><surname>Senstad</surname><given-names>R. E.</given-names></name><name><surname>Winkler</surname><given-names>A. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Identification of common variants associated with human hippocampal and intracranial volumes</article-title>. <source>Nat. Genet.</source>
<volume>44</volume>, <fpage>552</fpage>&#x02013;<lpage>561</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2250</pub-id><pub-id pub-id-type="pmid">22504417</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>B. W.</given-names></name><name><surname>Dibattista</surname><given-names>A. M.</given-names></name><name><surname>William Rebeck</surname><given-names>G.</given-names></name><name><surname>Green</surname><given-names>A. E.</given-names></name></person-group> (<year>2014</year>). <article-title>A gene-brain-cognition pathway for the effect of an Alzheimers risk gene on working memory in young adults</article-title>. <source>Neuropsychologia</source>
<volume>61</volume>, <fpage>143</fpage>&#x02013;<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2014.06.021</pub-id><pub-id pub-id-type="pmid">24967550</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Striepens</surname><given-names>N.</given-names></name><name><surname>Scheef</surname><given-names>L.</given-names></name><name><surname>Wind</surname><given-names>A.</given-names></name><name><surname>Meiberth</surname><given-names>D.</given-names></name><name><surname>Popp</surname><given-names>J.</given-names></name><name><surname>Spottke</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume</article-title>. <source>Psychol. Med.</source>
<volume>41</volume>, <fpage>1997</fpage>&#x02013;<lpage>2006</lpage>
<pub-id pub-id-type="doi">10.1017/s0033291711000067</pub-id><pub-id pub-id-type="pmid">21284913</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Striepens</surname><given-names>N.</given-names></name><name><surname>Scheef</surname><given-names>L.</given-names></name><name><surname>Wind</surname><given-names>A.</given-names></name><name><surname>Popp</surname><given-names>J.</given-names></name><name><surname>Spottke</surname><given-names>A.</given-names></name><name><surname>Cooper-Mahkorn</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Volume loss of the medial temporal lobe structures in subjective memory impairment</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>29</volume>, <fpage>75</fpage>&#x02013;<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1159/000264630</pub-id><pub-id pub-id-type="pmid">20110703</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomann</surname><given-names>P. A.</given-names></name><name><surname>Roth</surname><given-names>A. S.</given-names></name><name><surname>Dos Santos</surname><given-names>V.</given-names></name><name><surname>Toro</surname><given-names>P.</given-names></name><name><surname>Essig</surname><given-names>M.</given-names></name><name><surname>Schroder</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>26</volume>, <fpage>300</fpage>&#x02013;<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1159/000161054</pub-id><pub-id pub-id-type="pmid">18843182</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuminello</surname><given-names>E. R.</given-names></name><name><surname>Han</surname><given-names>S. D.</given-names></name></person-group> (<year>2011</year>). <article-title>The apolipoprotein E antagonistic pleiotropy hypothesis: review and recommendations</article-title>. <source>Int. J. Alzheimers Dis.</source>
<volume>2011</volume>:<fpage>726197</fpage>
<pub-id pub-id-type="doi">10.4061/2011/726197</pub-id><pub-id pub-id-type="pmid">21423560</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varon</surname><given-names>D.</given-names></name><name><surname>Loewenstein</surname><given-names>D. A.</given-names></name><name><surname>Potter</surname><given-names>E.</given-names></name><name><surname>Greig</surname><given-names>M. T.</given-names></name><name><surname>Agron</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment</article-title>. <source>Dement. Geriatr. Cogn. Disord.</source>
<volume>31</volume>, <fpage>276</fpage>&#x02013;<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1159/000324711</pub-id><pub-id pub-id-type="pmid">21494034</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>H. A.</given-names></name><name><surname>Saykin</surname><given-names>A. J.</given-names></name><name><surname>Mcallister</surname><given-names>T. W.</given-names></name><name><surname>Rabin</surname><given-names>L. A.</given-names></name><name><surname>Mcdonald</surname><given-names>B. C.</given-names></name><name><surname>Flashman</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele</article-title>. <source>Neurology</source>
<volume>67</volume>, <fpage>1221</fpage>&#x02013;<lpage>1224</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000238079.00472.3a</pub-id><pub-id pub-id-type="pmid">17030756</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zetterberg</surname><given-names>H.</given-names></name><name><surname>Alexander</surname><given-names>D. M.</given-names></name><name><surname>Spandidos</surname><given-names>D. A.</given-names></name><name><surname>Blennow</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Additional evidence for antagonistic pleiotropic effects of APOE</article-title>. <source>Alzheimers Dement.</source>
<volume>5</volume>:<fpage>75</fpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2008.10.005</pub-id><pub-id pub-id-type="pmid">19118812</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Nwabuisi-Heath</surname><given-names>E.</given-names></name><name><surname>Dumanis</surname><given-names>S. B.</given-names></name><name><surname>Tai</surname><given-names>L. M.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Rebeck</surname><given-names>G. W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>APOE genotype alters glial activation and loss of synaptic markers in mice</article-title>. <source>Glia</source>
<volume>60</volume>, <fpage>559</fpage>&#x02013;<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22289</pub-id><pub-id pub-id-type="pmid">22228589</pub-id></mixed-citation></ref></ref-list></back></article>